Cargando...
Recent Advances in Immunotherapy in Metastatic NSCLC
Non-small cell lung cancer (NSCLC) is one of most common malignancies and the leading cause of cancer deaths worldwide. Despite advances in targeted therapies, majority of NSCLC patients do not have targetable genomic alterations. Nevertheless, recent discovery that NSCLC is an immunogenic tumor typ...
Guardado en:
| Publicado en: | Front Oncol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5107578/ https://ncbi.nlm.nih.gov/pubmed/27896216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2016.00239 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|